The Vaccines and Related Biological Products Advisory Committee (VRBPAC) also discussed the need to target the long-simmering ...
As respiratory virus season approaches, you may be wondering if you should get the new COVID-19 vaccine to protect yourself. However, it may be more difficult for some people to find the shot this ...
Public health, explained: Sign up to receive Healthbeat’s free Atlanta newsletter here. Americans may get some movement – but maybe not much clarity – this week on their future access to Covid ...
This fall’s updated COVID-19 vaccines should target the SARS-CoV-2 XFG variant, the US Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee (VRBPAC) said ...
The FDA’s outside vaccine advisers overwhelmingly recommended Thursday that the agency direct manufacturers to base their 2026-2027 formulas on the dominant XFG Covid variant.
The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...
Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...
Read Coronavirus vaccine latest news on The Economic Times. When will coronavirus vaccine be available in India? Coronavirus ...
EDITOR’S NOTE: This story was originally published by HealthBeat. EDITOR’S NOTE: This story was originally published by HealthBeat. Americans may get some movement — but maybe not much clarity — this ...